s6y

4 Pathfinder Cell Therapy, Inc.: Statement of changes in beneficial ownership of securities

Filed
Period
Accession number
0001252874-11-000007

Documents

  1. PRIMARY DOCUMENT 4
  2. PRIMARY DOCUMENT 4

On sec.gov